Table 4.
Organization (Ref.) | Stated goals | % of mammograms judged to be abnormal |
% PPVB |
---|---|---|---|
Agency for Health Care Policy and Research (United States) (85) | General | ≤10 | 25–40 |
Europe Against Cancer Programme*(84) | Acceptable levels | <7 | >34 |
Europe Against Cancer Programme*(84) | Desirable levels | <5 | >50 |
For women aged 50–64 years at their initial screen.